A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Clinical trial NCT05519475 · RECRUITING
Trial details
- NCT number
- NCT05519475
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2028-04-27
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.